Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates

Darren B. Schneider, Christopher A Fly, David A. Dichek, Randolph L. Geary

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Arterial gene transfer with adenoviral vectors is a promising approach for the treatment and prevention of vascular disorders. However, in small animals such as rats and rabbits adenoviral vectors can have deleterious effects on the artery wall. The effects of adenovirus in primate arteries have not been studied, AdRSVn-LacZ, a replication-defective adenoviral vector, was delivered to the left brachial arteries of six hypercholesterolemic cynomolgus monkeys; right brachial arteries received vehicle only. Serum was collected before gene transfer and at vessel harvest 9 or 10 days later. Recombinant gene expression was present in occasional endothelial cells of transduced arteries, and all animals generated neutralizing antibodies. In transduced arteries, immunostaining revealed a fourfold increase in intimal and medial macrophage accumulation (p < 0.05); intimal cellularity was also significantly increased (twofold; p < 0.05). T cell density and total cellular proliferation (determined by bromodeoxyuridine labeling) were unaffected. In hypercholesterolemic nonhuman primates, adenoviral vectors increase vessel wall inflammation and promote the progression of early atherosclerotic lesions. The long-term consequences of these observations remain unclear; however, a better understanding of host responses to specific vector systems appears necessary for the development of safe and effective approaches to human vascular gene therapy.

Original languageEnglish (US)
Pages (from-to)815-821
Number of pages7
JournalHuman Gene Therapy
Volume9
Issue number6
DOIs
StatePublished - Apr 10 1998
Externally publishedYes

Fingerprint

Primates
Arteries
Tunica Intima
Brachial Artery
Genes
Blood Vessels
Macaca fascicularis
Bromodeoxyuridine
Neutralizing Antibodies
Adenoviridae
Genetic Therapy
Endothelial Cells
Cell Count
Macrophages
Cell Proliferation
Rabbits
Inflammation
T-Lymphocytes
Gene Expression
Serum

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates. / Schneider, Darren B.; Fly, Christopher A; Dichek, David A.; Geary, Randolph L.

In: Human Gene Therapy, Vol. 9, No. 6, 10.04.1998, p. 815-821.

Research output: Contribution to journalArticle

Schneider, Darren B. ; Fly, Christopher A ; Dichek, David A. ; Geary, Randolph L. / Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates. In: Human Gene Therapy. 1998 ; Vol. 9, No. 6. pp. 815-821.
@article{80139d6194304068930404197701dad3,
title = "Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates",
abstract = "Arterial gene transfer with adenoviral vectors is a promising approach for the treatment and prevention of vascular disorders. However, in small animals such as rats and rabbits adenoviral vectors can have deleterious effects on the artery wall. The effects of adenovirus in primate arteries have not been studied, AdRSVn-LacZ, a replication-defective adenoviral vector, was delivered to the left brachial arteries of six hypercholesterolemic cynomolgus monkeys; right brachial arteries received vehicle only. Serum was collected before gene transfer and at vessel harvest 9 or 10 days later. Recombinant gene expression was present in occasional endothelial cells of transduced arteries, and all animals generated neutralizing antibodies. In transduced arteries, immunostaining revealed a fourfold increase in intimal and medial macrophage accumulation (p < 0.05); intimal cellularity was also significantly increased (twofold; p < 0.05). T cell density and total cellular proliferation (determined by bromodeoxyuridine labeling) were unaffected. In hypercholesterolemic nonhuman primates, adenoviral vectors increase vessel wall inflammation and promote the progression of early atherosclerotic lesions. The long-term consequences of these observations remain unclear; however, a better understanding of host responses to specific vector systems appears necessary for the development of safe and effective approaches to human vascular gene therapy.",
author = "Schneider, {Darren B.} and Fly, {Christopher A} and Dichek, {David A.} and Geary, {Randolph L.}",
year = "1998",
month = "4",
day = "10",
doi = "10.1089/hum.1998.9.6-815",
language = "English (US)",
volume = "9",
pages = "815--821",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates

AU - Schneider, Darren B.

AU - Fly, Christopher A

AU - Dichek, David A.

AU - Geary, Randolph L.

PY - 1998/4/10

Y1 - 1998/4/10

N2 - Arterial gene transfer with adenoviral vectors is a promising approach for the treatment and prevention of vascular disorders. However, in small animals such as rats and rabbits adenoviral vectors can have deleterious effects on the artery wall. The effects of adenovirus in primate arteries have not been studied, AdRSVn-LacZ, a replication-defective adenoviral vector, was delivered to the left brachial arteries of six hypercholesterolemic cynomolgus monkeys; right brachial arteries received vehicle only. Serum was collected before gene transfer and at vessel harvest 9 or 10 days later. Recombinant gene expression was present in occasional endothelial cells of transduced arteries, and all animals generated neutralizing antibodies. In transduced arteries, immunostaining revealed a fourfold increase in intimal and medial macrophage accumulation (p < 0.05); intimal cellularity was also significantly increased (twofold; p < 0.05). T cell density and total cellular proliferation (determined by bromodeoxyuridine labeling) were unaffected. In hypercholesterolemic nonhuman primates, adenoviral vectors increase vessel wall inflammation and promote the progression of early atherosclerotic lesions. The long-term consequences of these observations remain unclear; however, a better understanding of host responses to specific vector systems appears necessary for the development of safe and effective approaches to human vascular gene therapy.

AB - Arterial gene transfer with adenoviral vectors is a promising approach for the treatment and prevention of vascular disorders. However, in small animals such as rats and rabbits adenoviral vectors can have deleterious effects on the artery wall. The effects of adenovirus in primate arteries have not been studied, AdRSVn-LacZ, a replication-defective adenoviral vector, was delivered to the left brachial arteries of six hypercholesterolemic cynomolgus monkeys; right brachial arteries received vehicle only. Serum was collected before gene transfer and at vessel harvest 9 or 10 days later. Recombinant gene expression was present in occasional endothelial cells of transduced arteries, and all animals generated neutralizing antibodies. In transduced arteries, immunostaining revealed a fourfold increase in intimal and medial macrophage accumulation (p < 0.05); intimal cellularity was also significantly increased (twofold; p < 0.05). T cell density and total cellular proliferation (determined by bromodeoxyuridine labeling) were unaffected. In hypercholesterolemic nonhuman primates, adenoviral vectors increase vessel wall inflammation and promote the progression of early atherosclerotic lesions. The long-term consequences of these observations remain unclear; however, a better understanding of host responses to specific vector systems appears necessary for the development of safe and effective approaches to human vascular gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=0032502889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032502889&partnerID=8YFLogxK

U2 - 10.1089/hum.1998.9.6-815

DO - 10.1089/hum.1998.9.6-815

M3 - Article

VL - 9

SP - 815

EP - 821

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 6

ER -